Publikationsliste A. Wollenberg

Publikationsliste A. Wollenberg

Stand 25.06.2021

Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were

Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.

Silverberg JI, Simpson EL, Wollenberg A, Bissonnette R, Kabashima K, DeLozier AM, Sun L, Cardillo T,

Nunes FP, Reich K.

JAMA Dermatol. 2021 Jun 1;157(6):691-699. doi: 10.1001/jamadermatol.2021.1273.

PMID: 33978711

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of

life, and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-

AD7 Phase 3 randomised trial.

Wollenberg A, Nakahara T, Maari C, Peris K, Lio P, Augustin M, Silverberg JI, Rueda MJ, DeLozier AM,

Pierce E, Yang FE, Sun L, Ball S, Tauber M, Paul C.

J Eur Acad Dermatol Venereol. 2021 Apr 8. doi: 10.1111/jdv.17278. Online ahead of print.

PMID: 33834521

"Face mask dermatitis" due to compulsory facial masks during the SARS-CoV-2 pandemic: data from

550 health care and non-health care workers in Germany.

Niesert AC, Oppel EM, Nellessen T, Frey S, Clanner-Engelshofen BM, Wollenberg A, French LE, Reinholz

M.

Eur J Dermatol. 2021 Apr 2. doi: 10.1684/ejd.2021.4007. Online ahead of print.

PMID: 33814358

Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic

Dermatitis: Results From a Phase 2b Study With Abrocitinib.

Simpson EL, Wollenberg A, Bissonnette R, Silverberg JI, Papacharalambous J, Zhu L, Zhang W, Beebe

JS, Vincent M, Peeva E, Bushmakin AG, Cappelleri JC, Chen L, Sikirica V, Xenakis J.

Dermatitis. 2021 Apr 1. doi: 10.1097/DER.0000000000000725. Online ahead of print.

PMID: 33795561

[Recommendations when switching therapy from immunosuppressive drugs to dupilumab in

patients with atopic dermatitis].

Wohlrab J, Mrowietz U, Weidinger S, Werfel T, Wollenberg A.

Hautarzt. 2021 Apr;72(4):321-327. doi: 10.1007/s00105-020-04720-1.

PMID: 33175219 Free PMC article. Review. German.

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases -

practical recommendations. A position statement of ETFAD with external experts.

Ring J, Worm M, Wollenberg A, Thyssen JP, Jakob T, Klimek L, Bangert C, Barbarot S, Bieber T, de Bruin-

Weller MS, Chernyshov PV, Christen-Zaech S, Cork M, Darsow U, Flohr C, Fölster-Holst R, Gelmetti C,

Gieler U, Gutermuth J, Heratizadeh A, Hijnen DJ, von Kobyletzki LB, Kunz B, Paul C, De Raeve L,

Seneschal J, Simon D, Spuls PI, Stalder JF, Svensson A, Szalai Z, Taieb A, Torrelo A, Trzeciak M,

Vestergaard C, Werfel T, Weidinger S, Deleuran M.

J Eur Acad Dermatol Venereol. 2021 Mar 22. doi: 10.1111/jdv.17237. Online ahead of print.

PMID: 33752263 Free article. No abstract available.

Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence.

Wollenberg A, Thomsen SF, Lacour JP, Jaumont X, Lazarewicz S.

World Allergy Organ J. 2021 Mar 19;14(3):100519. doi: 10.1016/j.waojou.2021.100519. eCollection

2021 Mar.

PMID: 33815652 Free PMC article. Review.

Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms:

subpopulation (EASI ≥ 16) analysis of randomized phase 2B study.

Silverberg JI, Pinter A, Alavi A, Lynde C, Bouaziz JD, Wollenberg A, Murrell DF, Alpizar S, Laquer V,

Chaouche K, Ahmad F, Armstrong JM, Piketty C.


PMID: 33711179

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab.

Frey S, Kendziora B, Holch JW, Lindner L, French LE, Wollenberg A.

Acta Derm Venereol. 2021 Mar 9;101(3):adv00409. doi: 10.2340/00015555-3734.


European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic

dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics.

Thyssen JP, Vestergaard C, Barbarot S, de Bruin-Weller MS, Bieber T, Taieb A, Seneschal J, Cork MJ,

Paul C, Flohr C, Weidinger S, Trzeciak M, Werfel T, Heratizadeh A, Darsow U, Simon D, Torrelo A,

Chernyshov PV, Stalder JF, Gelmetti C, Szalai Z, Svensson Å, von Kobyletzki LB, De Raeve L, Fölster-Holst

R, Christen-Zaech S, Hijnen DJ, Gieler U, Gutermuth J, Bangert C, Spuls PI, Kunz B, Ring J, Wollenberg

A, Deleuran M.

J Eur Acad Dermatol Venereol. 2021 May;35(5):e308-e311. doi: 10.1111/jdv.17167. Epub 2021 Mar 7.

PMID: 33587756 Free PMC article. No abstract available.

Cost-of-illness of atopic dermatitis in Germany: data from dermatology routine care.

Mohr N, Naatz M, Zeervi L, Langenbruch A, Bieber T, Werfel T, Wollenberg A, Augustin M.


PMID: 33651457

Inborn Error of Immunity or Atopic Dermatitis: When to be Concerned and How to Investigate.

Stadler PC, Renner ED, Milner J, Wollenberg A.

J Allergy Clin Immunol Pract. 2021 Apr;9(4):1501-1507. doi: 10.1016/j.jaip.2021.01.037. Epub 2021 Feb

3.

PMID: 33548520

Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis

(PSAAD) in Adolescents and Adults with Moderate-to-Severe AD.

Hall R, Lebwohl MG, Bushmakin AG, Simpson EL, Gooderham MJ, Wollenberg A, Gater A, Wells JR,

Cappelleri JC, Hsu MA, Papacharalambous J, Peeva E, Tallman AM, Zhang W, Chen L.

Dermatol Ther (Heidelb). 2021 Feb;11(1):221-233. doi: 10.1007/s13555-020-00474-9. Epub 2021 Feb

3.

PMID: 33382444 Free PMC article.

Update "Systemic treatment of atopic dermatitis" of the S2k-guideline on atopic dermatitis.

Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin M, Biedermann T, Diepgen T, Fölster-Holst R,

Kahle J, Kapp A, Nemat K, Peters E, Schlaeger M, Schmid-Grendelmeier P, Schmitt J, Schwennesen T,

Staab D, Traidl-Hoffmann C, Werner R, Wollenberg A, Worm M, Ott H. J Dtsch Dermatol Ges. 2021

Jan;19(1):151-168. doi: 10.1111/ddg.14371.

PMID: 33491884

Aktualisierung, Systemtherapie bei Neurodermitis“ zur S2k-Leitlinie Neurodermitis.

Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin M, Biedermann T, Diepgen T, Fölster-Holst R,

Kahle J, Kapp A, Nemat K, Peters E, Schlaeger M, Schmid-Grendelmeier P, Schmitt J, Schwennesen T,

Staab D, Traidl-Hoffmann C, Werner R, Wollenberg A, Worm M, Ott H. J Dtsch Dermatol Ges. 2021

Jan;19(1):151-169. doi: 10.1111/ddg.14371_g.

PMID: 33491881 German.

Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized,

double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).

Wollenberg A, Blauvelt A, Guttman-Yassky E, Worm M, Lynde C, Lacour JP, Spelman L, Katoh N, Saeki

H, Poulin Y, Lesiak A, Kircik L, Cho SH, Herranz P, Cork MJ, Peris K, Steffensen LA, Bang B, Kuznetsova

A, Jensen TN, Østerdal ML, Simpson EL; ECZTRA 1 and ECZTRA 2 study investigators. Br J Dermatol.

2021 Mar;184(3):437-449. doi: 10.1111/bjd.19574. Epub 2020 Dec 30.


Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis: A phase 2b

randomized study.

Silverberg JI, Guttman-Yassky E, Gooderham M, Worm M, Rippon S, O'Quinn S, van der Merwe R, Kragh

N, Kurbasic A, Wollenberg A.

Ann Allergy Asthma Immunol. 2020 Dec 15:S1081-1206(20)31242-4. doi: 10.1016/j.anai.2020.12.004.

Online ahead of print.

PMID: 33333295 Free article.

Evaluation of hand hygiene and onset of hand eczema after the outbreak of SARS-CoV-2 in Munich.

Kendziora B, Guertler A, Ständer L, Frey S, French LE, Wollenberg A, Reinholz M.

Eur J Dermatol. 2020 Dec 1;30(6):668-673. doi: 10.1684/ejd.2020.3923. PMID: 33289485 Free PMC

article.

Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and

inadequate response to topical corticosteroids: patient-reported outcomes from two randomized

monotherapy phase III trials.

Reich K, DeLozier AM, Nunes FP, Thyssen JP, Eichenfield LF, Wollenberg A, Ross Terres JA, Watts SD,

Chen YF, Simpson EL, Silverberg JI.

J Dermatolog Treat. 2020 Nov 22:1-10. doi: 10.1080/09546634.2020.1839008. Online ahead of print.

PMID: 33222559

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis

in adults and children.

Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M, Vestergaard C,

Seneschal J, Werfel T, Cork MJ, Kunz B, Fölster-Holst R, Trzeciak M, Darsow U, Szalai Z, Deleuran M,

von Kobyletzki L, Barbarot S, Heratizadeh A, Gieler U, Hijnen DJ, Weidinger S, De Raeve L, Svensson Å,

Simon D, Stalder JF, Ring J; European Task Force on Atopic Dermatitis/EADV Eczema Task Force.

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2717-2744. doi: 10.1111/jdv.16892. Epub 2020 Nov

17.


Impact of Atopic Dermatitis Lesion Location on Quality of Life in Adult Patients in a Real-world Study.

Lio PA, Wollenberg A, Thyssen JP, Pierce EJ, Rueda MJ, DeLozier AM, Ross Terres JA, Anderson P,

Milligan G, Piercy J, Silverberg JI, Paul C.

J Drugs Dermatol. 2020 Oct 1;19(10):943-948. doi: 10.36849/JDD.2020.5422.

PMID: 33026770

[A polymorphous exanthem with a solitary crust].

Nasifoglu S, Horvath O, Kapp F, Wollenberg A.

Hautarzt. 2020 Oct;71(10):827-829. doi: 10.1007/s00105-020-04583-6.

PMID: 32296854 German. No abstract available.

Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council.

Silverberg JI, Guttman-Yassky E, Agner T, Bissonnette R, Cohen DE, Simpson E, Wollenberg A, Thyssen

JP.

Dermatitis. 2020 Sep 30. doi: 10.1097/DER.0000000000000659. Online ahead of print.

PMID: 32991335

Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of

plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).

Lebwohl M, Kircik L, Lacour JP, Liljedahl M, Lynde C, Mørch MH, Papp KA, Perrot JL, Gold LS, Takhar A,

Thaçi D, Warren RB, Wollenberg A.

J Am Acad Dermatol. 2021 May;84(5):1269-1277. doi: 10.1016/j.jaad.2020.09.037. Epub 2020 Sep 18.


2020 European guideline on the management of genital molluscum contagiosum.

Edwards S, Boffa MJ, Janier M, Calzavara-Pinton P, Rovati C, Salavastru CM, Rongioletti F, Wollenberg

A, Butacu AI, Skerlev M, Tiplica GS.

J Eur Acad Dermatol Venereol. 2021 Jan;35(1):17-26. doi: 10.1111/jdv.16856. Epub 2020 Sep 2.

PMID: 32881110

Gene Mutation Mapping in a Fatal Case of Phacomatosis Pigmentokeratotica Happle.

Hayani K, Giehl K, Kumbrink J, Fischer J, Schlaak M, French LE, Wollenberg A.

Acta Derm Venereol. 2020 Aug 18;100(15):adv00241. doi: 10.2340/00015555-3599.


Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic

dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3

trial.

Simpson EL, Sinclair R, Forman S, Wollenberg A, Aschoff R, Cork M, Bieber T, Thyssen JP, Yosipovitch

G, Flohr C, Magnolo N, Maari C, Feeney C, Biswas P, Tatulych S, Valdez H, Rojo R.

Lancet. 2020 Jul 25;396(10246):255-266. doi: 10.1016/S0140-6736(20)30732-7.

PMID: 32711801 Free article. Clinical Trial.

[Surgical treatment of verrucous Darier disease].

Kämmerer T, Wollenberg A, Engels L, Rothenberger C, Betke M, Hartmann D, Flaig MJ.

Hautarzt. 2020 Jul;71(Suppl 1):60-62. doi: 10.1007/s00105-020-04643-x.


[Varicella vaccination and congenital immunodeficiency].

Mastnik S, Wollenberg A, Engels L.

Hautarzt. 2020 Jul;71(Suppl 1):38-40. doi: 10.1007/s00105-020-04622-2.


[Giant basal cell carcinoma on the leg and known HIV infection].

Srour J, Seegräber M, Nasifoglu S, Schlaak M, Wollenberg A, Flaig MJ, Sattler E.



[Palmoplantar contact dermatitis].

Zacher M, Niesert AC, Pinarci RM, Wollenberg A, Oppel EM.



Dupilumab for the treatment of adolescents with atopic dermatitis.

Senner S, Seegräber M, Frey S, Kendziora B, Eicher L, Wollenberg A.

Expert Rev Clin Immunol. 2020 Jul;16(7):641-650. doi: 10.1080/1744666X.2020.1801420. Epub 2020

Aug 13.

PMID: 32720530

European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic

dermatitis.

Thyssen JP, Vestergaard C, Deleuran M, de Bruin-Weller MS, Bieber T, Taieb A, Seneschal J, Cork MJ,

Paul C, Flohr C, Weidinger S, Trzeciak M, Werfel T, Heratizadeh A, Barbarot S, Darsow U, Simon D,

Torrelo A, Chernyshov PV, Stalder JF, Gelmetti C, Szalai Z, Svensson Å, von Kobyletzki LB, De Raeve L,

Fölster-Holst R, Cristen-Zaech S, Hijnen D, Gieler U, Ring J, Wollenberg A.

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e839-e842. doi: 10.1111/jdv.16716. Epub 2020 Jun 29.

PMID: 32515512 No abstract available.

Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years

old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.

Paller AS, Siegfried EC, Thaçi D, Wollenberg A, Cork MJ, Arkwright PD, Gooderham M, Beck LA,

Boguniewicz M, Sher L, Weisman J, O'Malley JT, Patel N, Hardin M, Graham NMH, Ruddy M, Sun X,

Davis JD, Kamal MA, Khokhar FA, Weinreich DM, Yancopoulos GD, Beazley B, Bansal A, Shumel B.

J Am Acad Dermatol. 2020 Nov;83(5):1282-1293. doi: 10.1016/j.jaad.2020.06.054. Epub 2020 Jun 20.


Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with

moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials.

Barbarot S, Wollenberg A, Silverberg JI, Deleuran M, Pellacani G, Armario-Hita JC, Chen Z, Shumel B,

Eckert L, Gadkari A, Lu Y, Rossi AB.

J Dermatolog Treat. 2020 Jun 8:1-12. doi: 10.1080/09546634.2020.1750550. Online ahead of print.

PMID: 32347763

Assessing the need for routine safety testing for patients being treated with dupilumab for

moderate-to-severe atopic dermatitis.

Wollenberg A, Beck LA, Blauvelt A, Simpson EL, Chen Z, Chen Q, Shumel B, Khokhar FA, Hultsch T,

Rizova E, Rossi AB, Graham NMH, Pirozzi G, Lu Y, Ardeleanu M.

Br J Dermatol. 2020 Jun;182(6):e186-e209. doi: 10.1111/bjd.19065.

PMID: 32476149

European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome

coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis.

Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S,

Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder

JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB,

Fölster-Holst R, Chernyshov PV, Christen-Zaech S, Heratizadeh A, Ring J, Vestergaard C.

J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e241-e242. doi: 10.1111/jdv.16411.

PMID: 32223003 Free article. Review. No abstract available.

Dupilumab prevents flares in adults with moderate to severe atopic dermatitis in a 52-week

randomized controlled phase 3 trial.

Merola JF, Sidbury R, Wollenberg A, Chen Z, Zhang A, Shumel B, Rossi AB.

J Am Acad Dermatol. 2021 Feb;84(2):495-497. doi: 10.1016/j.jaad.2020.05.003. Epub 2020 May 7.


[Psoriasis in dupilumab-treated atopic dermatitis].

Senner S, Eicher L, Aszodi N, Prinz JC, French LE, Wollenberg A.

Hautarzt. 2020 May;71(5):383-386. doi: 10.1007/s00105-020-04565-8.


Implementation of dupilumab in routine care of atopic eczema: results from the German national

registry TREATgermany.

Abraham S, Haufe E, Harder I, Heratizadeh A, Kleinheinz A, Wollenberg A, Weisshaar E, Augustin M,

Wiemers F, Zink A, Biedermann T, von Kiedrowski R, Hilgers M, Worm M, Pawlak M, Sticherling M, Fell

I, Handrick C, Schäkel K, Staubach P, Asmussen A, Schwarz B, Bell M, Neubert K, Effendy I, Bieber T,

Homey B, Gerlach B, Tchitcherina E, Stahl M, Schwichtenberg U, Rossbacher J, Buck P, Mempel M,

Beissert S, Werfel T, Weidinger S, Schmitt J; TREATgermany study group.

Br J Dermatol. 2020 Aug;183(2):382-384. doi: 10.1111/bjd.18958. Epub 2020 Apr 13.


Die Linienmuster der Haut und ihre Dermatosen.

Senner S, Eicher L, Nasifoglu S, Wollenberg A.

J Dtsch Dermatol Ges. 2020 Apr;18(4):341-365. doi: 10.1111/ddg.14066_g.


Linear patterns of the skin and their dermatoses.

Senner S, Eicher L, Nasifoglu S, Wollenberg A.

J Dtsch Dermatol Ges. 2020 Apr;18(4):341-364. doi: 10.1111/ddg.14066.

PMID: 32291926

Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical

corticosteroids: results from two randomized monotherapy phase III trials.

Simpson EL, Lacour JP, Spelman L, Galimberti R, Eichenfield LF, Bissonnette R, King BA, Thyssen JP,

Silverberg JI, Bieber T, Kabashima K, Tsunemi Y, Costanzo A, Guttman-Yassky E, Beck LA, Janes JM,

DeLozier AM, Gamalo M, Brinker DR, Cardillo T, Nunes FP, Paller AS, Wollenberg A, Reich K.

Br J Dermatol. 2020 Aug;183(2):242-255. doi: 10.1111/bjd.18898. Epub 2020 Mar 5.

PMID: 31995838

Coexistence of Oncogenic Human Papillomavirus Genotypes in Condylomata Acuminata among

Children and Adolescents.

Marsela E, Fischbeck AJ, Hildebrand JA, Aoki R, French LE, Wollenberg A, Schmoeckel E, Reinholz M.

Acta Derm Venereol. 2020 Feb 25;100(4):adv00061. doi: 10.2340/00015555-3407.


Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.

Ständer S, Yosipovitch G, Legat FJ, Lacour JP, Paul C, Narbutt J, Bieber T, Misery L, Wollenberg A, Reich

A, Ahmad F, Piketty C.

N Engl J Med. 2020 Feb 20;382(8):706-716. doi: 10.1056/NEJMoa1908316.

PMID: 32074418 Clinical Trial.

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis

included in the German AD Registry TREATgermany.

Heratizadeh A, Haufe E, Stölzl D, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, Weisshaar E,

Augustin M, Wiemers F, Zink A, von Kiedrowski R, Hilgers M, Worm M, Pawlak M, Sticherling M, Fell I,

Handrick C, Schäkel K, Staubach-Renz P, Asmussen A, Schwarz B, Bell M, Effendy I, Bieber T, Homey B,

Gerlach B, Tchitcherina E, Stahl M, Schwichtenberg U, Rossbacher J, Buck P, Mempel M, Beissert S,

Biedermann T, Weidinger S, Schmitt J, Werfel T; TREATgermany Study Group.

J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1263-1272. doi: 10.1111/jdv.16078. Epub 2020 Feb 13.

PMID: 31721316

European Task Force on Atopic Dermatitis (ETFAD) Position Paper: treatment of parental atopic

dermatitis during preconception, pregnancy and lactation period.

Vestergaard C, Wollenberg A, Thyssen JP.

J Eur Acad Dermatol Venereol. 2020 Feb;34(2):426-427. doi: 10.1111/jdv.16171.


Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical

characteristics of eczema herpeticum cases in atopic dermatitis patients.

Seegräber M, Worm M, Werfel T, Svensson A, Novak N, Simon D, Darsow U, Augustin M, Wollenberg

A.

J Eur Acad Dermatol Venereol. 2020 May;34(5):1074-1079. doi: 10.1111/jdv.16090. Epub 2020 Jan 30.


[Bullous pemphigoid on a healed herpes zoster: A rare example of an isotopic response].

Böhmer D, Seegräber M, Horváth ON, Wollenberg A.

Hautarzt. 2020 Jan;71(1):53-56. doi: 10.1007/s00105-019-4445-1.


Quality of care in atopic dermatitis - a position statement by the European Task Force on Atopic

Dermatitis (ETFAD).

Vestergaard C, Thyssen JP, Barbarot S, Paul C, Ring J, Wollenberg A.

J Eur Acad Dermatol Venereol. 2020 Mar;34(3):e136-e138. doi: 10.1111/jdv.16092. Epub 2019 Dec 5.

PMID: 31736172

The role of bacterial skin infections in atopic dermatitis: expert statement and review from the

International Eczema Council Skin Infection Group.

Alexander H, Paller AS, Traidl-Hoffmann C, Beck LA, De Benedetto A, Dhar S, Girolomoni G, Irvine AD,

Spuls P, Su J, Thyssen JP, Vestergaard C, Werfel T, Wollenberg A, Deleuran M, Flohr C.

Br J Dermatol. 2020 Jun;182(6):1331-1342. doi: 10.1111/bjd.18643. Epub 2019 Dec 4.


Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase

III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).

Wollenberg A, Beck LA, Blauvelt A, Simpson EL, Chen Z, Chen Q, Shumel B, Khokhar FA, Hultsch T,

Rizova E, Rossi AB, Graham NMH, Pirozzi G, Lu Y, Ardeleanu M.

Br J Dermatol. 2020 May;182(5):1120-1135. doi: 10.1111/bjd.18434. Epub 2019 Dec 1.


A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease

- strategies for optimizing treatment outcome.

Eicher L, Knop M, Aszodi N, Senner S, French LE, Wollenberg A.

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):2253-2263. doi: 10.1111/jdv.15913. Epub 2019 Nov

14.

PMID: 31454113

Efficacy of a skin care cream with TRPV1 inhibitor 4-t-butylcyclohexanol in the topical therapy of

perioral dermatitis.

Srour J, Bengel J, Linden T, Jovanovic Z, Roggenkamp D, Reinholz M, Rothenberger C, Neufang G,

Wollenberg A.

J Cosmet Dermatol. 2020 Jun;19(6):1409-1414. doi: 10.1111/jocd.13175. Epub 2019 Oct 29.


Retrospective analysis of alpha-human papillomavirus (HPV) types in tissue samples from anogenital

dysplasias - introduction of the RICH (Risk of HPV-related Carcinoma in HIV+/- patients) score.

Hildebrand JA, Fischbeck AJ, Hundsdoerfer B, Clanner-Engelshofen BM, Marsela E, Wollenberg A,

Flaig M, French LE, Reinholz M.

J Eur Acad Dermatol Venereol. 2020 Feb;34(2):377-384. doi: 10.1111/jdv.15932. Epub 2019 Oct 17.

PMID: 31494974

Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis

and severe pruritus.

Silverberg JI, Pinter A, Pulka G, Poulin Y, Bouaziz JD, Wollenberg A, Murrell DF, Alexis A, Lindsey L,

Ahmad F, Piketty C, Clucas A.

J Allergy Clin Immunol. 2020 Jan;145(1):173-182. doi: 10.1016/j.jaci.2019.08.013. Epub 2019 Aug 23.


Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic

Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials.

Alexis AF, Rendon M, Silverberg JI, Pariser DM, Lockshin B, Griffiths CE, Weisman J, Wollenberg A, Chen

Z, Davis JD, Li M, Eckert L, Gadkari A, Shumel B, Rossi AB, Graham NM, Ardeleanu M.

J Drugs Dermatol. 2019 Aug 1;18(8):804-813.


Pathomechanism of dupilumab-associated inflammatory eye symptoms.

Wohlrab J, Werfel T, Wollenberg A.

J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e435-e436. doi: 10.1111/jdv.15755. Epub 2019 Jul 3.


Perioral Dermatitis Successfully Treated with Topical Ivermectin.

Charnowski S, Wollenberg A, Reinholz M.

Ann Dermatol. 2019 Aug;31(Suppl):S27-S28. doi: 10.5021/ad.2019.31.S.S27. Epub 2019 Jul 1.

PMID: 33911686 Free PMC article. No abstract available.

Corrigendum: Consensus-based European guidelines for treatment of atopic eczema (atopic

dermatitis) in adults and children: part I.

Wollenberg A, Szepietowski J, Taieb A, Ring J.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1436. doi: 10.1111/jdv.15719.


European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis

during preconception, pregnancy and lactation period.

Vestergaard C, Wollenberg A, Barbarot S, Christen-Zaech S, Deleuran M, Spuls P, Flohr C, Trzeciak M,

von Kobyletzki L, Seneschal J, Paul C, Bieber T, Werfel T, Fölster-Holst R, Darsow U, Gieler U, Svensson

Å, Cork M, Stalder JF, De Raeve L, Kunz B, Simon D, Chernyshov P, Hijnen D, Gelmetti C, Ring J, Taieb

A, de Bruin-Weller M, Thyssen JP.

J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1644-1659. doi: 10.1111/jdv.15709. Epub 2019 Jun 23.

PMID: 31231864

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and

depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of

pooled data from the randomized trials SOLO 1 and SOLO 2.

Cork MJ, Eckert L, Simpson EL, Armstrong A, Barbarot S, Puig L, Girolomoni G, de Bruin-Weller M,

Wollenberg A, Kataoka Y, Remitz A, Beissert S, Mastey V, Ardeleanu M, Chen Z, Gadkari A, Chao J.

J Dermatolog Treat. 2020 Sep;31(6):606-614. doi: 10.1080/09546634.2019.1612836. Epub 2019 Jun 9.


Conjunctivitis in dupilumab clinical trials.

Akinlade B, Guttman-Yassky E, de Bruin-Weller M, Simpson EL, Blauvelt A, Cork MJ, Prens E, Asbell P,

Akpek E, Corren J, Bachert C, Hirano I, Weyne J, Korotzer A, Chen Z, Hultsch T, Zhu X, Davis JD, Mannent

L, Hamilton JD, Teper A, Staudinger H, Rizova E, Pirozzi G, Graham NMH, Shumel B, Ardeleanu M,

Wollenberg A.

Br J Dermatol. 2019 Sep;181(3):459-473. doi: 10.1111/bjd.17869. Epub 2019 May 7.


Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international

eczema council survey and opinion.

Thyssen JP, de Bruin-Weller MS, Paller AS, Leshem YA, Vestergaard C, Deleuran M, Drucker AM,

Foelster-Holst R, Traidl-Hoffmann C, Eyerich K, Taieb A, Su JC, Bieber T, Cork MJ, Eichenfield LF,

Guttman-Yassky E, Wollenberg A.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1224-1231. doi: 10.1111/jdv.15608. Epub 2019 May 6.


Management der Dupilumab-assoziierten Konjunktivitis beim atopischen Ekzem.

Aszodi N, Thurau S, Seegräber M, de Bruin-Weller M, Wollenberg A.

J Dtsch Dermatol Ges. 2019 May;17(5):488-492. doi: 10.1111/ddg.13809_g.

PMID: 31115977 Review.

[Dupilumab-Associated Healing of Alopecia Areata in an Atopic Dermatitis Patient].

Aszodi N, Pumnea T, Wollenberg A.

Dtsch Med Wochenschr. 2019 May;144(9):602-605. doi: 10.1055/a-0836-3119. Epub 2019 Apr 26.


Defining and measuring 'eczema control': an international qualitative study to explore the views of

those living with and treating atopic eczema.

Howells L, Thomas KS, Sears AV, Nasr I, Wollenberg A, Schuttelaar MLA, Romeijn GLE, Paller AS, Mueller

K, Doytcheva K, Kataoka Y, Daguze J, Barbarot S, von Kobyletzki LB, Beckman L, Ratib S, Cowdell F,

Santer M, Chalmers JR; long-term control of eczema working group for the HOME initiative.

J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1124-1132. doi: 10.1111/jdv.15475. Epub 2019 Apr 8.


Management of dupilumab-associated conjunctivitis in atopic dermatitis.

Aszodi N, Thurau S, Seegräber M, de Bruin-Weller M, Wollenberg A.

J Dtsch Dermatol Ges. 2019 May;17(5):488-491. doi: 10.1111/ddg.13809. Epub 2019 Mar 15.


Methotrexate in atopic eczema - Reply to a letter.

Wollenberg A, Deleuran M, Ring J.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e155-e156. doi: 10.1111/jdv.15377. Epub 2019 Mar 15.


Reply to a correspondence addressing the European guideline for treatment of atopic eczema,

functional textiles and the CLOTHES trial.

Wollenberg A, Schmid-Grendelmeier P, Christen-Zäch S, Ring J.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e153-e154. doi: 10.1111/jdv.15384. Epub 2019 Mar 15.


Tazarotene 0.015% Cream as a Potential Topical Agent for Management of Ichthyosis in Dorfman-

Chanarin Syndrome.

Niculescu L, Ruini C, Srour J, Salzer S, Schönbuchner I, von Braunmühl T, Ruzicka T, Hohenleutner U,

Giehl KA, Fischer J, Wollenberg A.

Acta Derm Venereol. 2019 Mar 1;99(3):345-346. doi: 10.2340/00015555-3087.


Silver, silk, atopic eczema and the CLOTHES trial - reply to a letter.

Wollenberg A, Srour J, Smolik T, Berg E, Mahltig B.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e169. doi: 10.1111/jdv.15401. Epub 2019 Feb 27.


Reply.

Wollenberg A, Thurau S, de Bruin-Weller M.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):753-754. doi: 10.1016/j.jaip.2018.10.054.


Food-Related Contact Dermatitis, Contact Urticaria, and Atopy Patch Test with Food.

Walter A, Seegräber M, Wollenberg A.

Clin Rev Allergy Immunol. 2019 Feb;56(1):19-31. doi: 10.1007/s12016-018-8687-y.


Atopic Dermatitis: Collegium Internationale Allergologicum (CIA) Update 2019.

Simon D, Wollenberg A, Renz H, Simon HU.

Int Arch Allergy Immunol. 2019;178(3):207-218. doi: 10.1159/000497383. Epub 2019 Feb 8.

PMID: 30739107 Free article. Review.

[Interdisciplinary recommendations for action in dupilumab-related inflammatory eye diseases].

Wohlrab J, Wollenberg A, Reimann H, Pleyer U, Werfel T.


PMID: 30478601 Review. German. No abstract available.

[Proceedings of the 13th congress of the German-Japanese Society of Dermatology].

Kapp F, Reinholz M, Wollenberg A, Jakob T, Hertl M, Wolf R, Ruzicka T.



A Case of Ankyloblepharon-ectodermal Defects-cleft Lip/Palate-syndrome with Choanal Atresia and

Skin Erosions: Phenotypic Variability of TP63-related Disorders.

Niculescu L, Wagner M, Westphal DS, Fischer M, Mihatsch W, Prothmann A, Ruzicka T, Wollenberg A,

Wolff H, Schmidt H, Giehl KA.

Acta Derm Venereol. 2019 Jan 1;99(1):111-112. doi: 10.2340/00015555-2997.


The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for

its inhibition.

Guttman-Yassky E, Hanifin JM, Boguniewicz M, Wollenberg A, Bissonnette R, Purohit V, Kilty I, Tallman

AM, Zielinski MA.

Exp Dermatol. 2019 Jan;28(1):3-10. doi: 10.1111/exd.13808. Epub 2018 Dec 12.


Human and computational models of atopic dermatitis: A review and perspectives by an expert

panel of the International Eczema Council.

Eyerich K, Brown SJ, Perez White BE, Tanaka RJ, Bissonette R, Dhar S, Bieber T, Hijnen DJ, Guttman-

Yassky E, Irvine A, Thyssen JP, Vestergaard C, Werfel T, Wollenberg A, Paller AS, Reynolds NJ.

J Allergy Clin Immunol. 2019 Jan;143(1):36-45. doi: 10.1016/j.jaci.2018.10.033. Epub 2018 Nov 7.


Pregnancy complications, treatment characteristics and birth outcomes in women with atopic

dermatitis in Denmark.

Hamann CR, Egeberg A, Wollenberg A, Gislason G, Skov L, Thyssen JP.

J Eur Acad Dermatol Venereol. 2019 Mar;33(3):577-587. doi: 10.1111/jdv.15256. Epub 2018 Oct 8.

PMID: 30242910

[Rickettsiosis in a child after a safari holiday].

Walter A, von Braunmühl T, Flaig MJ, Wollenberg A.

Hautarzt. 2018 Oct;69(Suppl 1):65-67. doi: 10.1007/s00105-018-4181-y.


[Varicella under the clinical picture of pityriasis lichenoides et varioliformis acuta (PLEVA)].

Pumnea T, Herzinger T, Wollenberg A, von Braunmühl T.

Hautarzt. 2018 Oct;69(Suppl 1):22-24. doi: 10.1007/s00105-018-4196-4.


[Atypical mycobacteriosis under the symptoms of Janeway lesions].

Srour J, Wollenberg A, Flaig MJ, Reinholz M.

Hautarzt. 2018 Oct;69(Suppl 1):39-41. doi: 10.1007/s00105-018-4197-3.


[Decreased professional performance and quality of life in patients with moderate-to-severe atopic

eczema: Results from the German atopic eczema registry TREATgermany].

Haufe E, Abraham S, Heratizadeh A, Harder I, Zink A, Weisshaar E, Kleinheinz A, von Kiedrowski R,

Worm M, Bell M, Wollenberg A, Neubert K, Staubach-Renz P, Hilgers M, Bieber T, Fell I, Homey B,

Effendy I, Mempel M, Schäkel K, Beissert S, Weidinger S, Werfel T, Schmitt J.

Hautarzt. 2018 Oct;69(10):815-824. doi: 10.1007/s00105-018-4261-z.


Evaluation of antimicrobial textiles for atopic dermatitis.

Srour J, Berg E, Mahltig B, Smolik T, Wollenberg A. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):384-

390. doi: 10.1111/jdv.15123. Epub 2018 Jul 12. PMID: 29894014

Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb.

Wollenberg A, Howell MD, Guttman-Yassky E, Silverberg JI, Kell C, Ranade K, Moate R, van der Merwe

R.

J Allergy Clin Immunol. 2019 Jan;143(1):135-141. doi: 10.1016/j.jaci.2018.05.029. Epub 2018 Jun 12.


Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults

and children: part II.

Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni

G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z,

Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J; European Dermatology Forum (EDF), the European

Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical

Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of

Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and

Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma

European Network (GA2LEN) and the European Union of Medical Specialists (UEMS).

J Eur Acad Dermatol Venereol. 2018 Jun;32(6):850-878. doi: 10.1111/jdv.14888.

PMID: 29878606

Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-

term extension study.

Kabashima K, Furue M, Hanifin JM, Pulka G, Wollenberg A, Galus R, Etoh T, Mihara R, Nakano M,

Ruzicka T.

J Allergy Clin Immunol. 2018 Oct;142(4):1121-1130.e7. doi: 10.1016/j.jaci.2018.03.018. Epub 2018

May 10.


Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults

and children: part I.

Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni

G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z,

Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J; European Dermatology Forum (EDF), the European

Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical

Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of

Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and

Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma

European Network (GA2LEN) and the European Union of Medical Specialists (UEMS).

J Eur Acad Dermatol Venereol. 2018 May;32(5):657-682. doi: 10.1111/jdv.14891.

PMID: 29676534

Report from the fifth international consensus meeting to harmonize core outcome measures for

atopic eczema/dermatitis clinical trials (HOME initiative).

Chalmers JR, Thomas KS, Apfelbacher C, Williams HC, Prinsen CA, Spuls PI, Simpson E, Gerbens LAA,

Boers M, Barbarot S, Stalder JF, Abuabara K, Aoki V, Ardeleanu M, Armstrong J, Bang B, Berents TL,

Burton T, Butler L, Chubachi T, Cresswell-Melville A, DeLozier A, Eckert L, Eichenfield L, Flohr C,

Futamura M, Gadkari A, Gjerde ES, van Halewijn KF, Hawkes C, Howells L, Howie L, Humphreys R, Ishii

HA, Kataoka Y, Katayama I, Kouwenhoven W, Langan SM, Leshem YA, Merhand S, Mina-Osorio P,

Murota H, Nakahara T, Nunes FP, Nygaard U, Nygårdas M, Ohya Y, Ono E, Rehbinder E, Rogers NK,

Romeijn GLE, Schuttelaar MLA, Sears AV, Simpson MA, Singh JA, Srour J, Stuart B, Svensson Å, Talmo

G, Talmo H, Teixeira HD, Thyssen JP, Todd G, Torchet F, Volke A, von Kobyletzki L, Weisshaar E,

Wollenberg A, Zaniboni M.

Br J Dermatol. 2018 May;178(5):e332-e341. doi: 10.1111/bjd.16543. Epub 2018 Apr 19.

PMID: 29672835

Effects of a protein-free oat plantlet extract on microinflammation and skin barrier function in atopic

dermatitis patients.

Wollenberg A, Fölster-Holst R, Saint Aroman M, Sampogna F, Vestergaard C.

J Eur Acad Dermatol Venereol. 2018 Apr;32 Suppl 1:1-15. doi: 10.1111/jdv.14846.


Dupilumab for treatment of atopic dermatitis.

Seegräber M, Srour J, Walter A, Knop M, Wollenberg A.

Expert Rev Clin Pharmacol. 2018 May;11(5):467-474. doi: 10.1080/17512433.2018.1449642. Epub

2018 Mar 20.


[Topical therapy for atopic eczema].

Knop M, Gürtler A, Heratizadeh A, Aszodi N, Werfel T, Wollenberg A.

Hautarzt. 2018 Mar;69(3):210-216. doi: 10.1007/s00105-018-4135-4.

PMID: 29487960 Review. German.

[Atopic eczema].

Wollenberg A, Biedermann T.

Hautarzt. 2018 Mar;69(3):190. doi: 10.1007/s00105-018-4140-7.


[New aspects in systemic treatment of atopic dermatitis].

Werfel T, Wollenberg A, Pumnea T, Heratizadeh A.

Hautarzt. 2018 Mar;69(3):217-224. doi: 10.1007/s00105-018-4131-8.


Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics

and treatment.

Wollenberg A, Ariens L, Thurau S, van Luijk C, Seegräber M, de Bruin-Weller M.

J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1778-1780.e1. doi: 10.1016/j.jaip.2018.01.034. Epub

2018 Feb 9.


[Paraneoplasms of the skin].

Gießen-Jung C, Wollenberg A, Reinholz M.

Internist (Berl). 2018 Feb;59(2):134-144. doi: 10.1007/s00108-017-0372-3.


Unopposed IL-36 Activity Promotes Clonal CD4+ T-Cell Responses with IL-17A Production in

Generalized Pustular Psoriasis.

Arakawa A, Vollmer S, Besgen P, Galinski A, Summer B, Kawakami Y, Wollenberg A, Dornmair K,

Spannagl M, Ruzicka T, Thomas P, Prinz JC.

J Invest Dermatol. 2018 Jun;138(6):1338-1347. doi: 10.1016/j.jid.2017.12.024. Epub 2017 Dec 27.


[Atopic eczema in childhood or primary immunodeficiency - what needs to be considered?].

Wollenberg A, Renner E, Hagl B.

MMW Fortschr Med. 2017 Nov;159(20):59-63. doi: 10.1007/s15006-017-0330-y.


European academy of dermatology and venereology European prurigo project: expert consensus on

the definition, classification and terminology of chronic prurigo.

Pereira MP, Steinke S, Zeidler C, Forner C, Riepe C, Augustin M, Bobko S, Dalgard F, Elberling J,

Garcovich S, Gieler U, Gonçalo M, Halvorsen JA, Leslie TA, Metz M, Reich A, Şavk E, Schneider G, Serra-

Baldrich E, Ständer HF, Streit M, Wallengren J, Weller K, Wollenberg A, Bruland P, Soto-Rey I, Storck

M, Dugas M, Weisshaar E, Szepietowski JC, Legat FJ, Ständer S; EADV Task Force Pruritus group

members.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1059-1065. doi: 10.1111/jdv.14570. Epub 2017 Sep 22.

PMID: 28857299

When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of

the International Eczema Council.

Simpson EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, Barbarot S, Deleuran M, Bieber T, Vestergaard

C, Brown SJ, Cork MJ, Drucker AM, Eichenfield LF, Foelster-Holst R, Guttman-Yassky E, Nosbaum A,

Reynolds NJ, Silverberg JI, Schmitt J, Seyger MMB, Spuls PI, Stalder JF, Su JC, Takaoka R, Traidl-

Hoffmann C, Thyssen JP, van der Schaft J, Wollenberg A, Irvine AD, Paller AS.

J Am Acad Dermatol. 2017 Oct;77(4):623-633. doi: 10.1016/j.jaad.2017.06.042. Epub 2017 Aug 10.

PMID: 28803668

What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone.

Silverberg JI, Thyssen JP, Paller AS, Drucker AM, Wollenberg A, Lee KH, Kabashima K, Todd G, Schmid-

Grendelmeier P, Bieber T.

Allergy. 2017 Dec;72(12):2026-2030. doi: 10.1111/all.13225. Epub 2017 Jun 30.

PMID: 28605026

Pustular erythema multiforme major associated with atypical pneumonia.

Wolf R, Ständer S, Well O, Frey L, Klier I, Brunner S, Flaig M, Wollenberg A, Ruzicka T.

J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e502-e503. doi: 10.1111/jdv.14356. Epub 2017 Jun

20.


[Persistent reddening and induration after wound cleansing with octenidine].

Seegräber M, T Ruzicka, Wollenberg A.

Hautarzt. 2017 Apr;68(4):326-328. doi: 10.1007/s00105-016-3895-y.


Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.

Ruzicka T, Hanifin JM, Furue M, Pulka G, Mlynarczyk I, Wollenberg A, Galus R, Etoh T, Mihara R, Yoshida

H, Stewart J, Kabashima K; XCIMA Study Group.

N Engl J Med. 2017 Mar 2;376(9):826-835. doi: 10.1056/NEJMoa1606490.


Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized

controlled trial.

Heratizadeh A, Werfel T, Wollenberg A, Abraham S, Plank-Habibi S, Schnopp C, Sticherling M,

Apfelbacher C, Biedermann T, Breuer K, Fell I, Fölster-Holst R, Heine G, Grimm J, Hennighausen L,

Kugler C, Reese I, Ring J, Schäkel K, Schmitt J, Seikowski K, von Stebut E, Wagner N, Waßmann-Otto A,

Wienke-Graul U, Weisshaar E, Worm M, Gieler U, Kupfer J; Arbeitsgemeinschaft

Neurodermitisschulung für Erwachsene (ARNE) Study Group.

J Allergy Clin Immunol. 2017 Sep;140(3):845-853.e3. doi: 10.1016/j.jaci.2017.01.029. Epub 2017 Feb

24.


Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M,

Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade

B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and

SOLO 2 Investigators.

N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30.


Dapsone treatment for eosinophilic anular erythema.

Alharbi R, Peric J, Wolff H, Wollenberg A.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):e153-e154. doi: 10.1111/jdv.13890. Epub 2016 Sep 12.


A practical approach to ichthyoses with systemic manifestations.

Saral S, Vural A, Wollenberg A, Ruzicka T.

Clin Genet. 2017 Jun;91(6):799-812. doi: 10.1111/cge.12828. Epub 2016 Aug 22.


Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.

Barbarot S, Rogers NK, Abuabara K, Aubert H, Chalmers J, Flohr C, Hanifin J, Naldi L, Margolis DJ, Paul

C, Ridd MJ, Schuttelaar MA, Simpson E, Tauber M, Volke A, Weidinger S, Wilkes SR, Wollenberg A,

Thomas KS.

J Am Acad Dermatol. 2016 Nov;75(5):1038-1044. doi: 10.1016/j.jaad.2016.05.043. Epub 2016 Aug 10.


Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.

Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon

HU, Wollenberg A, Bieber T, Lauener R, Schmid-Grendelmeier P, Traidl-Hoffmann C, Akdis CA.

J Allergy Clin Immunol. 2016 Aug;138(2):336-49. doi: 10.1016/j.jaci.2016.06.010.


Report from the fourth international consensus meeting to harmonize core outcome measures for

atopic eczema/dermatitis clinical trials (HOME initiative).

Chalmers JR, Simpson E, Apfelbacher CJ, Thomas KS, von Kobyletzki L, Schmitt J, Singh JA, Svensson Å,

Williams HC, Abuabara K, Aoki V, Ardeleanu M, Awici-Rasmussen M, Barbarot S, Berents TL, Block J,

Bragg A, Burton T, Bjerring Clemmensen KK, Creswell-Melville A, Dinesen M, Drucker A, Eckert L, Flohr

C, Garg M, Gerbens LA, Graff AL, Hanifin J, Heinl D, Humphreys R, Ishii HA, Kataoka Y, Leshem YA,

Marquort B, Massuel MA, Merhand S, Mizutani H, Murota H, Murrell DF, Nakahara T, Nasr I, Nograles

K, Ohya Y, Osterloh I, Pander J, Prinsen C, Purkins L, Ridd M, Sach T, Schuttelaar ML, Shindo S, Smirnova

J, Sulzer A, Synnøve Gjerde E, Takaoka R, Vestby Talmo H, Tauber M, Torchet F, Volke A, Wahlgren CF,

Weidinger S, Weisshaar E, Wollenberg A, Yamaga K, Zhao CY, Spuls PI.

Br J Dermatol. 2016 Jul;175(1):69-79. doi: 10.1111/bjd.14773. Epub 2016 Jul 19.

PMID: 27436240

Atypical Forms of Hand, Foot, and Mouth Disease: A Prospective Study of 47 Italian Children.

Neri I, Dondi A, Wollenberg A, Ricci L, Ricci G, Piccirilli G, Lazzarotto T, Patrizi A.

Pediatr Dermatol. 2016 Jul;33(4):429-37. doi: 10.1111/pde.12871. Epub 2016 Jun 13.

PMID: 27292085

[Spontaneously occurring, livid node of the umbilicus].

Ständer S, Wollenberg A, Wolf R.

Hautarzt. 2016 Jun;67(6):500-2. doi: 10.1007/s00105-016-3802-6.


ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis

in adult and paediatric patients.

Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, Kunz B, Svensson A, Barbarot S, von Kobyletzki

L, Taieb A, de Bruin-Weller M, Werfel T, Trzeciak M, Vestergard C, Ring J, Darsow U; European Task

Force on Atopic Dermatitis/EADV Eczema Task Force.

J Eur Acad Dermatol Venereol. 2016 May;30(5):729-47. doi: 10.1111/jdv.13599. Epub 2016 Mar 23.

PMID: 27004560

Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and

opportunities toward precision medicine.

Bieber T, Akdis C, Lauener R, Traidl-Hoffmann C, Schmid-Grendelmeier P, Schäppi G, Allam JP,

Apfelbacher C, Augustin M, Beck L, Biedermann T, Braun-Fahrländer C, Chew FT, Clavel T, Crameri R,

Darsow U, Deleuran M, Dittlein D, Duchna HW, Eichenfeld L, Eyerich K, Frei R, Gelmetti C, Gieler U,

Gilles S, Glatz M, Grando K, Green J, Gutermuth J, Guttman-Yassky E, Hanifin J, Hijnen D, Hoetzenecker

W, Irvine A, Kalweit A, Katoh N, Knol E, Koren H, Möhrenschlager M, Münch D, Novak N, O'Mahony L,

Paller AS, Rhyner C, Roduit C, Schiesser K, Schröder J, Simon D, Simon HU, Sokolowska M, Spuls P,

Stalder JF, Straub D, Szalai Z, Taieb A, Takaoka R, Todd G, Todorova A, Vestergaard C, Werfel T,

Wollenberg A, Ring J.

Allergy. 2016 May;71(5):588-92. doi: 10.1111/all.12857. Epub 2016 Mar 8.


Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.

Hagl B, Heinz V, Schlesinger A, Spielberger BD, Sawalle-Belohradsky J, Senn-Rauh M, Magg T, Boos AC,

Hönig M, Schwarz K, Dückers G, von Bernuth H, Pache C, Karitnig-Weiss C, Belohradsky BH, Frank J,

Niehues T, Wahn V, Albert MH, Wollenberg A, Jansson AF, Renner ED.

Pediatr Allergy Immunol. 2016 Mar;27(2):177-84. doi: 10.1111/pai.12512. Epub 2016 Jan 26.

PMID: 26592211

Neurogenic inflammation and colliquative lymphadenitis with persistent orthopox virus DNA

detection in a human case of cowpox virus infection transmitted by a domestic cat.

Hobi S, Mueller RS, Hill M, Nitsche A, Löscher T, Guggemos W, Ständer S, Rjosk-Dendorfer D,

Wollenberg A.

Br J Dermatol. 2015 Aug;173(2):535-9. doi: 10.1111/bjd.13700. Epub 2015 May 18.

PMID: 25641516

IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform

skin lesions of patients with Crohn's disease.

Friedrich M, Tillack C, Wollenberg A, Schauber J, Brand S.

Inflamm Bowel Dis. 2014 Nov;20(11):1891-901. doi: 10.1097/MIB.0000000000000198.

PMID: 25299544

Photoallergic contact dermatitis due to treatment of pulmonary fibrosis with pirfenidone.

Reinholz M, Eder I, Przybilla B, Schauber J, Wollenberg A, Wulffen W, Goldscheider I, Varga R, Ruzicka

T, Schaumann A, Ruëff F.

J Eur Acad Dermatol Venereol. 2016 Feb;30(2):370-1. doi: 10.1111/jdv.12794. Epub 2014 Oct 20.


Contact sensitization in patients with suspected cosmetic intolerance: results of the IVDK 2006-2011.

Dinkloh A, Worm M, Geier J, Schnuch A, Wollenberg A.

J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1071-81. doi: 10.1111/jdv.12750. Epub 2014 Oct 7.

PMID: 25288472

Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide

Efficacy in Perioral Dermatitis (TOLPOD) Study.

Ehmann L, Reinholz M, Maier T, Lang M, Wollenberg A.

Ann Dermatol. 2014 Aug;26(4):462-8. doi: 10.5021/ad.2014.26.4.462. Epub 2014 Jul 31.


Psychodermatological aspects of atopic dermatitis.

Senra MS, Wollenberg A.

Br J Dermatol. 2014 Jul;170 Suppl 1:38-43. doi: 10.1111/bjd.13084.


Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.

Boos AC, Hagl B, Schlesinger A, Halm BE, Ballenberger N, Pinarci M, Heinz V, Kreilinger D, Spielberger

BD, Schimke-Marques LF, Sawalle-Belohradsky J, Belohradsky BH, Przybilla B, Schaub B, Wollenberg A,

Renner ED.

Allergy. 2014 Jul;69(7):943-53. doi: 10.1111/all.12416.

PMID: 24898675

Immunological and molecular targets of atopic dermatitis treatment.

Wollenberg A, Seba A, Antal AS.

Br J Dermatol. 2014 Jul;170 Suppl 1:7-11. doi: 10.1111/bjd.12975. Epub 2014 May 9.


Introduction to the Pierre Fabre supplement.

Wollenberg A.

Br J Dermatol. 2014 Jul;170 Suppl 1:1. doi: 10.1111/bjd.12974. Epub 2014 May 9.


Atopic dermatitis - all you can do from the outside.

Gelmetti C, Wollenberg A.

Br J Dermatol. 2014 Jul;170 Suppl 1:19-24. doi: 10.1111/bjd.12957. Epub 2014 May 9.


Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of

cytokinesis 8 deficiency.

Papan C, Hagl B, Heinz V, Albert MH, Ehrt O, Sawalle-Belohradsky J, Neumann J, Ries M, Bufler P,

Wollenberg A, Renner ED.

J Allergy Clin Immunol. 2014 May;133(5):1456-8. doi: 10.1016/j.jaci.2014.02.008. Epub 2014 Apr 1.


Atopic dermatitis and skin allergies - update and outlook.

Wollenberg A, Feichtner K.

Allergy. 2013 Dec;68(12):1509-19. doi: 10.1111/all.12324. Epub 2013 Nov 26.


Patch testing for noncontact dermatitis: the atopy patch test for food and inhalants.

Wollenberg A, Vogel S.

Curr Allergy Asthma Rep. 2013 Oct;13(5):539-44. doi: 10.1007/s11882-013-0368-6.


Epidermal EGFR controls cutaneous host defense and prevents inflammation.

Lichtenberger BM, Gerber PA, Holcmann M, Buhren BA, Amberg N, Smolle V, Schrumpf H, Boelke E,

Ansari P, Mackenzie C, Wollenberg A, Kislat A, Fischer JW, Röck K, Harder J, Schröder JM, Homey B,

Sibilia M.

Sci Transl Med. 2013 Aug 21;5(199):199ra111. doi: 10.1126/scitranslmed.3005886.


Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.

Prucha H, Schnopp C, Akdis C, Lauener R, Wollenberg A, Ring J, Traidl-Hoffmann C.

Expert Opin Drug Metab Toxicol. 2013 Nov;9(11):1507-16. doi: 10.1517/17425255.2013.819343. Epub

2013 Jul 22. PMID: 23876065 Review.

Oxazolone and ethanol induce colitis in non-obese diabetic-severe combined immunodeficiency

interleukin-2Rγ(null) mice engrafted with human peripheral blood mononuclear cells.

Nolte T, Zadeh-Khorasani M, Safarov O, Rueff F, Gülberg V, Herbach N, Wollenberg A, Mueller T,

Siebeck M, Wolf E, Gropp R.

Clin Exp Immunol. 2013 May;172(2):349-62. doi: 10.1111/cei.12057.


Difficult to control atopic dermatitis.

Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M,

Calza AM, Giusti F, Lübbe J, Seidenari S, Ring J; European Task Force on Atopic Dermatitis / EADV

Eczema Task Force.

World Allergy Organ J. 2013 Mar 14;6(1):6. doi: 10.1186/1939-4551-6-6.


Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease

are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and

respond to anti-IL-12/IL-23 antibody treatment.

Tillack C, Ehmann LM, Friedrich M, Laubender RP, Papay P, Vogelsang H, Stallhofer J, Beigel F, Bedynek

A, Wetzke M, Maier H, Koburger M, Wagner J, Glas J, Diegelmann J, Koglin S, Dombrowski Y, Schauber

J, Wollenberg A, Brand S.

Gut. 2014 Apr;63(4):567-77. doi: 10.1136/gutjnl-2012-302853. Epub 2013 Mar 6.

PMID: 23468464

Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent

progenitor cell.

Groesser L, Herschberger E, Sagrera A, Shwayder T, Flux K, Ehmann L, Wollenberg A, Torrelo A,

Bagazgoitia L, Diaz-Ley B, Tinschert S, Oschlies I, Singer S, Mickler M, Toll A, Landthaler M, Real FX,

Hafner C.

J Invest Dermatol. 2013 Aug;133(8):1998-2003. doi: 10.1038/jid.2013.24. Epub 2013 Jan 21.


NOD-scid IL2R γnull mice engrafted with human peripheral blood mononuclear cells as a model to

test therapeutics targeting human signaling pathways.

Zadeh-Khorasani M, Nolte T, Mueller TD, Pechlivanis M, Rueff F, Wollenberg A, Fricker G, Wolf E,

Siebeck M, Gropp R.

J Transl Med. 2013 Jan 7;11:4. doi: 10.1186/1479-5876-11-4.


Allergy or tolerance: reduced inflammatory cytokine response and concomitant IL-10 production of

lymphocytes and monocytes in symptom-free titanium dental implant patients.

Thomas P, Iglhaut G, Wollenberg A, Cadosch D, Summer B.

Biomed Res Int. 2013;2013:539834. doi: 10.1155/2013/539834. Epub 2013 Sep 11.


Management of difficult-to-treat atopic dermatitis.

Arkwright PD, Motala C, Subramanian H, Spergel J, Schneider LC, Wollenberg A; Atopic Dermatitis

Working Group of the Allergic Skin Diseases Committee of the AAAAI.

J Allergy Clin Immunol Pract. 2013 Mar;1(2):142-51. doi: 10.1016/j.jaip.2012.09.002. Epub 2012 Dec

14.


Cutaneous vasculitis after renal transplantation: a case report.

Rau S, Wollenberg A, Weiss M, Fischereder M, Schönermarck U.

Transplant Proc. 2012 Dec;44(10):3048-50. doi: 10.1016/j.transproceed.2012.04.037. Epub 2012 Sep

15.


Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T,

Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski

JC, Taïeb A, Werfel T, Wollenberg A, Darsow U; European Dermatology Forum (EDF); European

Academy of Dermatology and Venereology (EADV); European Federation of Allergy (EFA); European

Task Force on Atopic Dermatitis (ETFAD); European Society of Pediatric Dermatology (ESPD); Global

Allergy and Asthma European Network (GA2LEN).

J Eur Acad Dermatol Venereol. 2012 Aug;26(8):1045-60. doi: 10.1111/j.1468-3083.2012.04635.x.

PMID: 22805051

Towards global consensus on outcome measures for atopic eczema research: results of the HOME II

meeting.

Schmitt J, Spuls P, Boers M, Thomas K, Chalmers J, Roekevisch E, Schram M, Allsopp R, Aoki V,

Apfelbacher C, Bruijnzeel-Koomen C, Bruin-Weller M, Charman C, Cohen A, Dohil M, Flohr C, Furue M,

Gieler U, Hooft L, Humphreys R, Ishii HA, Katayama I, Kouwenhoven W, Langan S, Lewis-Jones S,

Merhand S, Murota H, Murrell DF, Nankervis H, Ohya Y, Oranje A, Otsuka H, Paul C, Rosenbluth Y, Saeki

H, Schuttelaar ML, Stalder JF, Svensson A, Takaoka R, Wahlgren CF, Weidinger S, Wollenberg A,

Williams H.

Allergy. 2012 Sep;67(9):1111-7. doi: 10.1111/j.1398-9995.2012.02874.x. Epub 2012 Jul 30.

PMID: 22844983

Long term treatment concepts and proactive therapy for atopic eczema.

Wollenberg A, Ehmann LM.

Ann Dermatol. 2012 Aug;24(3):253-60. doi: 10.5021/ad.2012.24.3.253. Epub 2012 Jul 25.


Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rγ(null) mice

engrafted with human peripheral blood mononuclear cells.

Nolte T, Zadeh-Khorasani M, Safarov O, Rueff F, Varga R, Herbach N, Wanke R, Wollenberg A, Mueller

T, Gropp R, Wolf E, Siebeck M.

Dis Model Mech. 2013 Jan;6(1):125-34. doi: 10.1242/dmm.009167. Epub 2012 Jul 19.


Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.

Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T,

Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski

JC, Taïeb A, Werfel T, Wollenberg A, Darsow U; European Dermatology Forum; European Academy of

Dermatology and Venereology; European Task Force on Atopic Dermatitis; European Federation of

Allergy; European Society of Pediatric Dermatology; Global Allergy and Asthma European Network.

J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1176-93. doi: 10.1111/j.1468-3083.2012.04636.x. Epub

2012 Jul 19.


Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its

correlation with parameters of the epidermal growth factor receptor signal transduction pathway:

results from a randomized trial of the GERMAN AIO CRC Study Group.

Stintzing S, Kapaun C, Laubender RP, Jung A, Neumann J, Modest DP, Giessen C, Moosmann N,

Wollenberg A, Kirchner T, Heinemann V. Int J Cancer. 2013 Jan 1;132(1):236-45. doi: 10.1002/ijc.27654.

Epub 2012 Jun 26.


Escalating therapy of cutaneous side effects of EGFR inhibitors: experience of German reference

centers.

Homey B, Gerber PA, Wollenberg A, Dirschka T, Hassel JC, Bölke E, Hauschild A, Gutzmer R.

J Dtsch Dermatol Ges. 2012 Aug;10(8):559-63. doi: 10.1111/j.1610-0387.2012.07948.x. Epub 2012 Jun

4.

PMID: 22672156 Free article. Review. English, German.

[Paraneoplastic palmoplantar hyperkeratosis. Minor form of acrokeratosis neoplastica Bazex?].

Ehmann LM, Grahovac M, Kramer M, Ruzicka T, Wollenberg A.

Hautarzt. 2012 Jun;63(6):477-9. doi: 10.1007/s00105-011-2253-3.


The Munich outbreak of cutaneous cowpox infection: transmission by infected pet rats.

Vogel S, Sárdy M, Glos K, Korting HC, Ruzicka T, Wollenberg A.

Acta Derm Venereol. 2012 Mar;92(2):126-31. doi: 10.2340/00015555-1227.


Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.

Gerber PA, Meller S, Eames T, Buhren BA, Schrumpf H, Hetzer S, Ehmann LM, Budach W, Bölke E,

Matuschek C, Wollenberg A, Homey B. Eur J Med Res. 2012 Feb 23;17(1):4. doi: 10.1186/2047-783X-

17-4. PMID: 22472354 Free PMC article.

Cutaneous side effects of new antitumor drugs: clinical features and management.

Gutzmer R, Wollenberg A, Ugurel S, Homey B, Ganser A, Kapp A.

Dtsch Arztebl Int. 2012 Feb;109(8):133-40. doi: 10.3238/arztebl.2012.0133. Epub 2012 Feb 24.


Neutrophilic eccrine hidradenitis induced by cytarabine.

Grahovac M, Maximiliane Ehmann L, Flaig M, Reibke R, Wollenberg A.

Acta Dermatovenerol Croat. 2012;20(4):272-5.


Eczema herpeticum.

Wollenberg A.

Chem Immunol Allergy. 2012;96:89-95. doi: 10.1159/000331892. Epub 2012 Mar 13.

PMID: 22433376

Innate immunity in atopic dermatitis.

Wollenberg A, Räwer HC, Schauber J.

Clin Rev Allergy Immunol. 2011 Dec;41(3):272-81. doi: 10.1007/s12016-010-8227-x.


[New tyrosine kinase and EGFR inhibitors in cancer therapy. Cardiac and skin toxicity as relevant side

effects. Part B: Skin].

Ehmann LM, Heinemann V, Wollenberg A.

Internist (Berl). 2011 Nov;52(11):1359-64. doi: 10.1007/s00108-011-2896-2.


Malignant melanoma during ustekinumab therapy of Crohn's disease.

Ehmann LM, Tillack-Schreiber C, Brand S, Wollenberg A.

Inflamm Bowel Dis. 2012 Jan;18(1):E199-200. doi: 10.1002/ibd.21877. Epub 2011 Oct 10.


Isotopic response, Köbner phenomenon and Renbök phenomenon following herpes zoster.

Kroth J, Tischer J, Samtleben W, Weiss C, Ruzicka T, Wollenberg A.

J Dermatol. 2011 Nov;38(11):1058-61. doi: 10.1111/j.1346-8138.2011.01329.x. Epub 2011 Sep 20.

PMID: 21933259

[Multiple Sister Mary Joseph's nodules in a patient with gastric cancer].

Ehmann LM, Fiegl M, Wollenberg A.

Dtsch Med Wochenschr. 2011 Jun;136(25-26):1365-8. doi: 10.1055/s-0031-1280556. Epub 2011 Jun

14.


[The first guideline for perioral dermatitis].

Wollenberg A.

J Dtsch Dermatol Ges. 2011 May;9(5):347-8. doi: 10.1111/j.1610-0387.2010.07689.x.


Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated

in Europe.

Stalder JF, Barbarot S, Wollenberg A, Holm EA, De Raeve L, Seidenari S, Oranje A, Deleuran M,

Cambazard F, Svensson A, Simon D, Benfeldt E, Reunala T, Mazereeuv J, Boralevi F, Kunz B, Misery L,

Mortz CG, Darsow U, Gelmetti C, Diepgen T, Ring J, Moehrenschlager M, Gieler U, Taïeb A; PO-SCORAD

Investigators Group.

Allergy. 2011 Aug;66(8):1114-21. doi: 10.1111/j.1398-9995.2011.02577.x. Epub 2011 Mar 18.

PMID: 21414011

Skin diseases following a Christmas tree pattern.

Wollenberg A, Eames T.

Clin Dermatol. 2011 Mar-Apr;29(2):189-94. doi: 10.1016/j.clindermatol.2010.09.011.

PMID: 21396559

Mannan-binding lectin levels and activity are not altered in atopic dermatitis patients with a history

of eczema herpeticum.

Bundy KW, McGirt LY, Bankova LG, Wollenberg A, Beck LA, De Benedetto A.

Dermatol Res Pract. 2011;2011:769890. doi: 10.1155/2011/769890. Epub 2011 Nov 10.


Cutaneous side-effects of EGFR inhibitors and their management.

Ehmann LM, Ruzicka T, Wollenberg A.

Skin Therapy Lett. 2011 Jan;16(1):1-3.


Genital ulcers associated with Epstein-Barr virus infection (ulcus vulvae acutum).

Sárdy M, Wollenberg A, Niedermeier A, Flaig MJ.

Acta Derm Venereol. 2011 Jan;91(1):55-9. doi: 10.2340/00015555-0979.


Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis.

Kümpfel T, Gerdes LA, Flaig M, Hohlfeld R, Wollenberg A.

Mult Scler. 2011 Apr;17(4):495-7. doi: 10.1177/1352458510390069. Epub 2010 Dec 9.

PMID: 21148263

Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus

Meeting (HOME 1), 24 July 2010, Munich, Germany.

Schmitt J, Williams H; HOME Development Group.

Br J Dermatol. 2010 Dec;163(6):1166-8. doi: 10.1111/j.1365-2133.2010.10054.x.

PMID: 21137114

Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert

panel for the primary treating physician.

Gutzmer R, Becker JC, Enk A, Garbe C, Hauschild A, Leverkus M, Reimer G, Treudler R, Tsianakas A,

Ulrich C, Wollenberg A, Homey B.

J Dtsch Dermatol Ges. 2011 Mar;9(3):195-203. doi: 10.1111/j.1610-0387.2010.07561.x. Epub 2010 Nov

8.

PMID: 21059173 English, German.

[Vaccinations with atopic dermatitis and other chronic inflammatory skin diseases].

Wollenberg A, Vogel S, Renner ED.

Hautarzt. 2010 Nov;61(11):985-93; quiz 994. doi: 10.1007/s00105-010-2019-3.


Perioral dermatitis.

Wollenberg A, Bieber T, Dirschka T, Luger T, Meurer M, Proksch E, Schön MP, Schwarz T, Thaçi D,

Zuberbier T, Werfel T; German Society of Dermatology.

J Dtsch Dermatol Ges. 2011 May;9(5):422-7. doi: 10.1111/j.1610-0387.2010.07329.x. Epub 2010 Oct

8.

PMID: 21040469 English, German. No abstract available.

Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to

differentiate hyper-IgE syndromes from atopic dermatitis.

Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, Rieber N, Cremer R,

Maass E, Dopfer R, Reichenbach J, Wahn V, Hoenig M, Jansson AF, Roesen-Wolff A, Schaub B, Seger R,

Hill HR, Ochs HD, Torgerson TR, Belohradsky BH, Renner ED.

J Allergy Clin Immunol. 2010 Sep;126(3):611-7.e1. doi: 10.1016/j.jaci.2010.06.029.

PMID: 20816194

Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion.

Potthoff K, Hofheinz R, Hassel JC, Volkenandt M, Lordick F, Hartmann JT, Karthaus M, Riess H, Lipp HP,

Hauschild A, Trarbach T, Wollenberg A.

Ann Oncol. 2011 Mar;22(3):524-535. doi: 10.1093/annonc/mdq387. Epub 2010 Aug 13.


Fulminant primary manifestations of Wegener's granulomatosis might not be pauci-immune.

Schönermarck U, Grahovac M, Sárdy M, Dolch M, Wollenberg A.

NDT Plus. 2010 Dec;3(6):567-9. doi: 10.1093/ndtplus/sfq145. Epub 2010 Aug 5.


Evolution of conventional therapy in atopic dermatitis.

Wollenberg A, Schnopp C.

Immunol Allergy Clin North Am. 2010 Aug;30(3):351-68. doi: 10.1016/j.iac.2010.06.005.


[Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib].

Wollenberg A, Staehler M, Eames T.

Hautarzt. 2010 Aug;61(8):662-7. doi: 10.1007/s00105-010-1942-7.


Perifollicular xanthomas associated with epidermal growth factor receptor inhibitor therapy.

Eames T, Kroth J, Flaig MJ, Ruzicka T, Wollenberg A.

Acta Derm Venereol. 2010 Mar;90(2):202-3. doi: 10.2340/00015555-0792.


[Cutaneous side effects of EGFR inhibitors--appearance and management].

Wollenberg A, Kroth J, Hauschild A, Dirschka T.

Dtsch Med Wochenschr. 2010 Jan;135(4):149-54. doi: 10.1055/s-0029-1244831. Epub 2010 Jan 25.


Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated

paronychia.

Eames T, Grabein B, Kroth J, Wollenberg A.

J Eur Acad Dermatol Venereol. 2010 Aug;24(8):958-60. doi: 10.1111/j.1468-3083.2009.03516.x. Epub

2009 Dec 8.

PMID: 20015177

Treatment of atopic eczema with oral alitretinoin.

Grahovac M, Molin S, Prinz JC, Ruzicka T, Wollenberg A.

Br J Dermatol. 2010 Jan;162(1):217-8. doi: 10.1111/j.1365-2133.2009.09522.x. Epub 2009 Nov 3.


Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions

caused by the EGFR-inhibitor cetuximab - A report of 29 patients.

Katzer K, Tietze J, Klein E, Heinemann V, Ruzicka T, Wollenberg A.

Eur J Dermatol. 2010 Jan-Feb;20(1):82-4. doi: 10.1684/ejd.2010.0806. Epub 2009 Oct 2.


ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis.

Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M,

Calza AM, Giusti F, Lübbe J, Seidenari S, Ring J; European Task Force on Atopic Dermatitis/EADV Eczema

Task Force.

J Eur Acad Dermatol Venereol. 2010 Mar;24(3):317-28. doi: 10.1111/j.1468-3083.2009.03415.x. Epub

2009 Aug 31.


[Hematologic neoplasias and solid tumors in pregnancy. Part 2: Specific treatment].

Popp H, Spiekermann K, Wollenberg A, Spitzweg C, Loehrs B.

Dtsch Med Wochenschr. 2009 Feb;134(8):361-4. doi: 10.1055/s-0028-1124006. Epub 2009 Feb 10.


[Hematologic neoplasias and solid tumors in pregnancy. Part 1: diagnosis and principal treatment

options].

Popp H, Spiekermann K, Wollenberg A, Spitzweg C, Loehrs B.

Dtsch Med Wochenschr. 2009 Feb;134(7):311-5. doi: 10.1055/s-0028-1123998. Epub 2009 Feb 5.


Proactive therapy of atopic dermatitis--an emerging concept.

Wollenberg A, Bieber T.

Allergy. 2009 Feb;64(2):276-8. doi: 10.1111/j.1398-9995.2008.01803.x. Epub 2008 Nov 28.


Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with

moderate to severe atopic dermatitis.

Wollenberg A, Sidhu MK, Odeyemi I, Dorsch B, Koehne-Volland R, Schaff M, Ehlken B, Berger K.

Br J Dermatol. 2008 Dec;159(6):1322-30. doi: 10.1111/j.1365-2133.2008.08807.x. Epub 2008 Sep 6.


Proactive therapy of atopic eczema--an evidence-based concept with a behavioral background.

Wollenberg A, Frank R, Kroth J, Ruzicka T.

J Dtsch Dermatol Ges. 2009 Feb;7(2):117-21. doi: 10.1111/j.1610-0387.2008.06772.x. Epub 2008 Aug

7.

PMID: 18691346 Review. English, German.

A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and

adult patients.

Reitamo S, Rustin M, Harper J, Kalimo K, Rubins A, Cambazard F, Brenninkmeijer EE, Smith C, Berth-

Jones J, Ruzicka T, Sharpe G, Taieb A; 0.1% Tacrolimus Ointment Long-term Follow-up Study Group.

Br J Dermatol. 2008 Sep;159(4):942-51. doi: 10.1111/j.1365-2133.2008.08747.x. Epub 2008 Jul 15.

PMID: 18637898

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.

Wollenberg A, Reitamo S, Girolomoni G, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J,

Deleuran M; European Tacrolimus Ointment Study Group.

Allergy. 2008 Jul;63(7):742-50.


Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.

Wollenberg A, Reitamo S, Atzori F, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran

M; European Tacrolimus Ointment Study Group.

Allergy. 2008 Jun;63(6):742-50. doi: 10.1111/j.1398-9995.2008.01683.x.

PMID: 18445188 Corrected and republished. Clinical Trial.

A tool for scoring of acneiform skin eruptions induced by EGF receptor inhibition.

Wollenberg A, Moosmann N, Klein E, Katzer K.

Exp Dermatol. 2008 Sep;17(9):790-2. doi: 10.1111/j.1600-0625.2008.00715.x. Epub 2008 May 22.

PMID: 18503553

A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients

with perioral dermatitis.

Schwarz T, Kreiselmaier I, Bieber T, Thaci D, Simon JC, Meurer M, Werfel T, Zuberbier T, Luger TA,

Wollenberg A, Bräutigam M.

J Am Acad Dermatol. 2008 Jul;59(1):34-40. doi: 10.1016/j.jaad.2008.03.043. Epub 2008 May 7.


Leser-Trelat sign in metastasized malignant melanoma.

Siedek V, Schuh T, Wollenberg A.

Eur Arch Otorhinolaryngol. 2009 Feb;266(2):297-9. doi: 10.1007/s00405-008-0636-6. Epub 2008 Mar

28.

PMID: 18369652

PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse.

Neynaber S, Mistry-Burchardi N, Rust C, Samtleben W, Burgdorf WH, Seitz MA, Messer G, Wollenberg

A.

Acta Derm Venereol. 2008;88(6):594-6. doi: 10.2340/00015555-0514.


Pollen grains induce a rapid and biphasic eczematous immune response in atopic eczema patients.

Eyerich K, Huss-Marp J, Darsow U, Wollenberg A, Foerster S, Ring J, Behrendt H, Traidl-Hoffmann C.

Int Arch Allergy Immunol. 2008;145(3):213-23. doi: 10.1159/000109290. Epub 2007 Oct 3.


Current aspects of innate and adaptive immunity in atopic dermatitis.

Wollenberg A, Klein E.

Clin Rev Allergy Immunol. 2007 Oct;33(1-2):35-44. doi: 10.1007/s12016-007-0032-9.


Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind,

vehicle-controlled study in 40 patients.

Oppel T, Pavicic T, Kamann S, Bräutigam M, Wollenberg A.

J Eur Acad Dermatol Venereol. 2007 Oct;21(9):1175-80. doi: 10.1111/j.1468-3083.2007.02191.x.


Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib.

Boeck S, Wollenberg A, Heinemann V.

Ann Oncol. 2007 Sep;18(9):1582-3. doi: 10.1093/annonc/mdm420.


[Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and

topical corticosteroid].

Wollenberg A, Moosmann N, Kroth J, Heinemann V, Klein E.

Hautarzt. 2007 Jul;58(7):615-8. doi: 10.1007/s00105-006-1256-y.


Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind

trial.

Weissenbacher S, Merkl J, Hildebrandt B, Wollenberg A, Braeutigam M, Ring J, Hofmann H.

Br J Dermatol. 2007 Apr;156(4):728-32. doi: 10.1111/j.1365-2133.2006.07669.x.


[Topical calcineurin inhibitors in atopic eczema -- pro].

Wollenberg A.

Dtsch Med Wochenschr. 2006 Jul 14;131(28-29):1614. doi: 10.1055/s-2006-947807. PMID: 16823713

German. No abstract available.

[Eczema herpeticum: Pathogenesis and therapy].

Rerinck HC, Kamann S, Wollenberg A.

Hautarzt. 2006 Jul;57(7):586-91. doi: 10.1007/s00105-006-1168-x.


Cathelicidin deficiency predisposes to eczema herpeticum.

Howell MD, Wollenberg A, Gallo RL, Flaig M, Streib JE, Wong C, Pavicic T, Boguniewicz M, Leung DY.

J Allergy Clin Immunol. 2006 Apr;117(4):836-41. doi: 10.1016/j.jaci.2005.12.1345. Epub 2006 Feb 14.


Scoring of skin lesions with the perioral dermatitis severity index (PODSI).

Wollenberg A, Oppel T.

Acta Derm Venereol. 2006;86(3):251-2. doi: 10.2340/00015555-0044.


Cross-sensitization between poppy seed and buckwheat in a food-allergic patient with poppy seed

anaphylaxis.

Oppel T, Thomas P, Wollenberg A.

Int Arch Allergy Immunol. 2006;140(2):170-3. doi: 10.1159/000092557. Epub 2006 Apr 5.


Position paper on diagnosis and treatment of atopic dermatitis.

Darsow U, Lübbe J, Taïeb A, Seidenari S, Wollenberg A, Calza AM, Giusti F, Ring J; European Task Force

on Atopic Dermatitis.

J Eur Acad Dermatol Venereol. 2005 May;19(3):286-95. doi: 10.1111/j.1468-3083.2005.01249.x.

PMID: 15857453

The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in

subjects with atopic eczema: a European multicenter study.

Darsow U, Laifaoui J, Kerschenlohr K, Wollenberg A, Przybilla B, Wüthrich B, Borelli S Jr, Giusti F,

Seidenari S, Drzimalla K, Simon D, Disch R, Borelli S, Devillers AC, Oranje AP, De Raeve L, Hachem JP,

Dangoisse C, Blondeel A, Song M, Breuer K, Wulf A, Werfel T, Roul S, Taieb A, Bolhaar S, Bruijnzeel-

Koomen C, Brönnimann M, Braathen LR, Didierlaurent A, André C, Ring J.

Allergy. 2004 Dec;59(12):1318-25. doi: 10.1111/j.1398-9995.2004.00556.x.


Smallpox, vaccination and adverse reactions to smallpox vaccine.

Wollenberg A, Engler R.

Curr Opin Allergy Clin Immunol. 2004 Aug;4(4):271-5. doi: 10.1097/01.all.0000136758.66442.28.


Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell

apoptosis in patients with atopic dermatitis.

Schuller E, Oppel T, Bornhövd E, Wetzel S, Wollenberg A.

J Allergy Clin Immunol. 2004 Jul;114(1):137-43. doi: 10.1016/j.jaci.2004.03.021.

PMID: 15241357

[Diagnosis and treatment of eyelid eczema. An interdisciplinary challenge].

Wollenberg A, Kerschenlohr K, Pavicic T, Messmer EM.

Hautarzt. 2004 Jul;55(7):677-87; quiz 688. doi: 10.1007/s00105-004-0759-7. PMID: 15197462 Review.

German.

Lessons from atopy patch testing in atopic dermatitis.

Kerschenlohr K, Darsow U, Burgdorf WH, Ring J, Wollenberg A.

Curr Allergy Asthma Rep. 2004 Jul;4(4):285-9. doi: 10.1007/s11882-004-0072-7.


[Eczema herpeticatum].

Wetzel S, Wollenberg A.

Hautarzt. 2004 Jul;55(7):646-52. doi: 10.1007/s00105-004-0744-1.


Eczema molluscatum in tacrolimus treated atopic dermatitis.

Wetzel S, Wollenberg A.

Eur J Dermatol. 2004 Jan-Feb;14(1):73-4.

PMID: 14965804

Viral infections in atopic dermatitis: pathogenic aspects and clinical management.

Wollenberg A, Wetzel S, Burgdorf WH, Haas J.

J Allergy Clin Immunol. 2003 Oct;112(4):667-74. doi: 10.1016/j.jaci.2003.07.001.


Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100

cases.

Wollenberg A, Zoch C, Wetzel S, Plewig G, Przybilla B.

J Am Acad Dermatol. 2003 Aug;49(2):198-205. doi: 10.1067/s0190-9622(03)00896-x.

PMID: 12894065

Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients

with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis.

Kerschenlohr K, Decard S, Przybilla B, Wollenberg A.

J Allergy Clin Immunol. 2003 Apr;111(4):869-74. doi: 10.1067/mai.2003.1347.

PMID: 12704371

[Eyelid eczema. A therapeutic challenge].

Kerschenlohr K, Schaller UC, Messmer EM, Wollenberg A.

Ophthalmologe. 2003 Mar;100(3):240-50; quiz 251. doi: 10.1007/s00347-002-0734-6.


Topical treatment with imiquimod may induce regression of facial keratoacanthoma.

Dendorfer M, Oppel T, Wollenberg A, Prinz JC.

Eur J Dermatol. 2003 Jan-Feb;13(1):80-2. PMID: 12609789

Clinical and immunologic reactivity to aeroallergens in "intrinsic" atopic dermatitis patients.

Kerschenlohr K, Decard S, Darsow U, Ollert M, Wollenberg A.

J Allergy Clin Immunol. 2003 Jan;111(1):195-7. doi: 10.1016/s0091-6749(03)70068-2.


Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory

skin diseases.

Wollenberg A, Wagner M, Günther S, Towarowski A, Tuma E, Moderer M, Rothenfusser S, Wetzel S,

Endres S, Hartmann G.

J Invest Dermatol. 2002 Nov;119(5):1096-102. doi: 10.1046/j.1523-1747.2002.19515.x.


Is topical tacrolimus effective in alopecia areata universalis?

Feldmann KA, Kunte C, Wollenberg A, Wolfe H.

Br J Dermatol. 2002 Nov;147(5):1031-2. doi: 10.1046/j.1365-2133.2002.500210.x.


Enhanced expression and activity of protein-tyrosine kinases establishes a functional signaling

pathway only in FcepsilonRIhigh Langerhans cells from atopic individuals.

Kraft S, Wessendorf JH, Haberstok J, Novak N, Wollenberg A, Bieber T.

J Invest Dermatol. 2002 Oct;119(4):804-11. doi: 10.1046/j.1523-1747.2002.00282.x.


Acrodermatitis chronica atrophicans affecting all four limbs in an 11-year-old girl.

Brzonova I, Wollenberg A, Prinz JC.

Br J Dermatol. 2002 Aug;147(2):375-8. doi: 10.1046/j.1365-2133.2002.04792.x.


Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.

Bornhövd EC, Burgdorf WH, Wollenberg A.

Curr Opin Investig Drugs. 2002 May;3(5):708-12.


[Anthrenus dermatitis].

Horster S, Prinz JC, Holm N, Wollenberg A.

Hautarzt. 2002 May;53(5):328-31. doi: 10.1007/s001050100257.


Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment

in adult patients with atopic dermatitis.

Reitamo S, Rustin M, Ruzicka T, Cambazard F, Kalimo K, Friedmann PS, Schoepf E, Lahfa M, Diepgen TL,

Judodihardjo H, Wollenberg A, Berth-Jones J, Bieber T; European Tacrolimus Ointment Study Group. J

Allergy Clin Immunol. 2002 Mar;109(3):547-55. doi: 10.1067/mai.2002.121832.


Expression and function of the mannose receptor CD206 on epidermal dendritic cells in

inflammatory skin diseases.

Wollenberg A, Mommaas M, Oppel T, Schottdorf EM, Günther S, Moderer M.

J Invest Dermatol. 2002 Feb;118(2):327-34. doi: 10.1046/j.0022-202x.2001.01665.x.


Long-lasting "christmas tree rash" in an adolescent: isotopic response of indeterminate cell

histiocytosis in pityriasis rosea?

Wollenberg A, Burgdorf WH, Schaller M, Sander C.

Acta Derm Venereol. 2002;82(4):288-91. doi: 10.1080/000155502320323270.


Phacomatosis pigmentokeratotica (Happle) in a 23-year-old man.

Wollenberg A, Butnaru C, Oppel T.

Acta Derm Venereol. 2002;82(1):55-7. doi: 10.1080/000155502753600911.


Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy.

Schaller M, Romiti R, Wollenberg A, Prinz B, Woerle B.

J Am Acad Dermatol. 2001 Dec;45(6):969-70. doi: 10.1067/mjd.2001.117248.


Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.

Bornhövd E, Burgdorf WH, Wollenberg A.

J Am Acad Dermatol. 2001 Nov;45(5):736-43. doi: 10.1067/mjd.2001.117525.


Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily,

in Chanarin-Dorfman syndrome.

Lefèvre C, Jobard F, Caux F, Bouadjar B, Karaduman A, Heilig R, Lakhdar H, Wollenberg A, Verret JL,

Weissenbach J, Ozgüc M, Lathrop M, Prud'homme JF, Fischer J.

Am J Hum Genet. 2001 Nov;69(5):1002-12. doi: 10.1086/324121. Epub 2001 Oct 2.

PMID: 11590543

In situ expression of the costimulatory molecules CD80 and CD86 on langerhans cells and

inflammatory dendritic epidermal cells (IDEC) in atopic dermatitis.

Schuller E, Teichmann B, Haberstok J, Moderer M, Bieber T, Wollenberg A.

Arch Dermatol Res. 2001 Sep;293(9):448-54. doi: 10.1007/s004030100263.

PMID: 11758787

Topical immunomodulatory agents and their targets in inflammatory skin diseases.


Transplant Proc. 2001 May;33(3):2212-6. doi: 10.1016/s0041-1345(01)01944-3.

PMID: 11377505 Review. No abstract available.

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal

antigen-presenting dendritic cells in atopic dermatitis.

Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T.

J Allergy Clin Immunol. 2001 Mar;107(3):519-25. doi: 10.1067/mai.2001.112942.


Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic

forms of atopic dermatitis.

Oppel T, Schuller E, Günther S, Moderer M, Haberstok J, Bieber T, Wollenberg A.

Br J Dermatol. 2000 Dec;143(6):1193-8. doi: 10.1046/j.1365-2133.2000.03887.x.

PMID: 11122020

Fc [correction of Ec] epsilon RI expressing dendritic cells: the missing link in the pathophysiology of

atopic dermatitis?

Bieber T, Kraft S, Geiger E, Wollenberg A, Koch S, Novak N.

J Dermatol. 2000 Nov;27(11):698-9. doi: 10.1111/j.1346-8138.2000.tb02261.x.


Atopic dermatitis: pathogenetic mechanisms.

Wollenberg A, Kraft S, Oppel T, Bieber T.

Clin Exp Dermatol. 2000 Oct;25(7):530-4. doi: 10.1046/j.1365-2230.2000.00699.x.


[Immunosuppressive macrolides and their use in dermatology].

Bornhövd EC, Schuller E, Bieber T, Wollenberg A.

Hautarzt. 2000 Sep;51(9):646-54. doi: 10.1007/s001050051189.


Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis.

The European Tacrolimus Ointment Study Group.

Reitamo S, Wollenberg A, Schöpf E, Perrot JL, Marks R, Ruzicka T, Christophers E, Kapp A, Lahfa M,

Rubins A, Jablonska S, Rustin M.

Arch Dermatol. 2000 Aug;136(8):999-1006. doi: 10.1001/archderm.136.8.999.


Atopic dermatitis: from the genes to skin lesions.


Allergy. 2000 Mar;55(3):205-13. doi: 10.1034/j.1398-9995.2000.00115.x.


Dorfman-Chanarin syndrome in a Turkish kindred: conductor diagnosis requires analysis of multiple

eosinophils.

Wollenberg A, Geiger E, Schaller M, Wolff H.

Acta Derm Venereol. 2000 Jan-Feb;80(1):39-43. doi: 10.1080/000155500750012504.


Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod.

Wollenberg A, Wen S, Bieber T.

Cytometry. 1999 Oct 1;37(2):147-55.

PMID: 10486527

Demonstration of the low-affinity IgE receptor Fc epsilonRII/CD23 in psoriatic epidermis:

inflammatory dendritic epidermal cells (IDEC) but not Langerhans cells are the relevant CD1a-

positive cell population.

Wollenberg A, Haberstok J, Teichmann B, Wen SP, Bieber T.



IL-10 inhibits ICAM-1 expression on human Langerhans cells but not on keratinocytes, dermal

endothelial cells or fibroblasts.

Chatelain R, Wollenberg A, Martin C, Panhans-Gross A, Bieber T, Degitz K, Heckmann M.


PMID: 9808340

Two populations of CD1a+ epidermal dendritic cells expressing B7 molecules in human skin.


Br J Dermatol. 1998 Feb;138(2):358-9. doi: 10.1046/j.1365-2133.1998.02093.x.


Aquarium dermatitis: cercarial dermatitis in an aquarist.

Bastert J, Sing A, Wollenberg A, Korting HC.

Dermatology. 1998;197(1):84-6. doi: 10.1159/000017965.


[Dorfman-Chanarin syndrome--a neutral lipid storage disease].

Wollenberg A, Schaller M, Röschinger W, Schirren CG, Wolff H.

Hautarzt. 1997 Oct;48(10):753-8. doi: 10.1007/s001050050656.


Chronic ulcerative stomatitis.

Wörle B, Wollenberg A, Schaller M, Kunzelmann KH, Plewig G, Meurer M.

Br J Dermatol. 1997 Aug;137(2):262-5. doi: 10.1046/j.1365-2133.1997.18171898.x.

PMID: 9292078

Acne conglobata and Klinefelter's syndrome.

Wollenberg A, Wolff H, Jansen T, Schmid MH, Röcken M, Plewig G.

Br J Dermatol. 1997 Mar;136(3):421-3.

PMID: 9115930

Erythema annulare centrifugum and intestinal Candida albicans infection--coincidence or

connection?

Schmid MH, Wollenberg A, Sander CA, Bieber T.

Acta Derm Venereol. 1997 Jan;77(1):93-4. doi: 10.2340/00015555779394.


Urticaria haemorrhagica profunda.

Wollenberg A, Hänel S, Spannagl M, Sander C, Plewig G.

Br J Dermatol. 1997 Jan;136(1):108-11.

PMID: 9039306

New insights in the structure and biology of the high affinity receptor for IgE (Fc epsilon RI) on human

epidermal Langerhans cells.

Bieber T, Kraft S, Jürgens M, Strobel I, Haberstok J, Tomov H, Regele D, de la Salle H, Wollenberg A,

Hanau D.

J Dermatol Sci. 1996 Oct;13(1):71-5. doi: 10.1016/0923-1811(95)00504-8.

PMID: 8902656

Linear atrophoderma of Moulin: a disease which follows Blaschko's lines.

Wollenberg A, Baumann L, Plewig G.

Br J Dermatol. 1996 Aug;135(2):277-9.


Immunomorphological and ultrastructural characterization of Langerhans cells and a novel,

inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema.

Wollenberg A, Kraft S, Hanau D, Bieber T.

J Invest Dermatol. 1996 Mar;106(3):446-53. doi: 10.1111/1523-1747.ep12343596.


Detection of herpes simplex virus in exacerbated pemphigus vulgaris by polymerase chain reaction.

Schlüpen EM, Wollenberg A, Hänel S, Stumpenhausen G, Volkenandt M.

Dermatology. 1996;192(4):312-6. doi: 10.1159/000246401.

PMID: 8864363

Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases.

Wollenberg A, Wen S, Bieber T.

Lancet. 1995 Dec 16;346(8990):1626-7. doi: 10.1016/s0140-6736(95)91958-9.


Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE,

Fc epsilon RI.

Jürgens M, Wollenberg A, Hanau D, de la Salle H, Bieber T.

J Immunol. 1995 Dec 1;155(11):5184-9.

PMID: 7594528

[Herpetic eczema in pregnancy].

Wollenberg A, Degitz K.

Dtsch Med Wochenschr. 1995 Oct 13;120(41):1395-8. doi: 10.1055/s-2008-1055490.


Multiple superficial basal cell carcinomas (basalomatosis) following cobalt irradiation.

Wollenberg A, Peter RU, Przybilla B.

Br J Dermatol. 1995 Oct;133(4):644-6. doi: 10.1111/j.1365-2133.1995.tb02722.x.

PMID: 7577601

Characterization of the protein tyrosine phosphatase CD45 on human epidermal Langerhans cells.

Bieber T, Jürgens M, Wollenberg A, Sander E, Hanau D, de la Salle H.

Eur J Immunol. 1995 Feb;25(2):317-21. doi: 10.1002/eji.1830250202.

PMID: 7875193

Ultraviolet-A radiation induces adhesion molecule expression on human dermal microvascular

endothelial cells.

Heckmann M, Eberlein-König B, Wollenberg A, Przybilla B, Plewig G.

Br J Dermatol. 1994 Sep;131(3):311-8. doi: 10.1111/j.1365-2133.1994.tb08516.x.

PMID: 7522515

Human keratinocytes release the endogenous beta-galactoside-binding soluble lectin

immunoglobulin E (IgE-binding protein) which binds to Langerhans cells where it modulates their

binding capacity for IgE glycoforms.

Wollenberg A, de la Salle H, Hanau D, Liu FT, Bieber T.

J Exp Med. 1993 Sep 1;178(3):777-85. doi: 10.1084/jem.178.3.777.


Release of soluble Fc gamma RII/CD32 molecules by human Langerhans cells: a subtle balance

between shedding and secretion?

de la Salle C, Esposito-Farese ME, Bieber T, Moncuit J, Morales M, Wollenberg A, de la Salle H, Fridman

WH, Cazenave JP, Teillaud JL, et al.

J Invest Dermatol. 1992 Nov;99(5):15S-17S. doi: 10.1111/1523-1747.ep12668250.

PMID: 1431201

Expression of the high-affinity receptor for IgE (Fc epsilon RI) on human Langerhans cells: the end of

a dogma.

Bieber T, de la Salle H, de la Salle C, Hanau D, Wollenberg A.

J Invest Dermatol. 1992 Nov;99(5):10S-11S. doi: 10.1111/1523-1747.ep12668204.


[Erosive pustular dermatosis of the scalp after zoster ophthalmicus and trauma].

Wollenberg A, Heckmann M, Braun-Falco O.

Hautarzt. 1992 Sep;43(9):576-9.


Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc

epsilon RI).

Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, Hanau D, de la Salle C.

J Exp Med. 1992 May 1;175(5):1285-90. doi: 10.1084/jem.175.5.1285.


[Thiazide diuretic-induced subacute cutaneous lupus erythematosus].

Wollenberg A, Meurer M.

Hautarzt. 1991 Nov;42(11):709-12.


Publikationsliste A. Wollenberg

Documents

Transcript of Publikationsliste A. Wollenberg